Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 7, 1998, Pages 685-690

  Luo, Jiing Chyuan ^a   Hwang, Shinn Jang ^a,b   Lai, Chiung Ru ^a   Lu, Ching Liang ^a   Li, Chung Pin ^a   Tsay, Shyh Haw ^a   Wu, Jaw Ching ^a   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Alanine aminotransferase; Chronic hepatitis C; Hepatitis C viral genotype; Hepatitis C viral RNA; Histological activity index

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS GENE;

EID: 0031782291     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00714.x     Document Type: Article

References (34)

1. McCormick SE, Goodman ZD, Maydonovitch CL, Sjogren MH. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C. Am. J. Gastroenterol 1996; 91: 1516-22.
2. Yano M, Kumada H, Kage M et al. The long term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-40.
3. Merican I, Sherlock S, McIntyre N, Dusheiko GM. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Q. J. Med. 1993; 86: 119-25.
4. Healey CJ, Chapman RWG, Fleming KA. Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 1995; 37: 274-8.
5. Haber MM, West AB, Haber AD, Reuben A. Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am. J. Gastroenterol. 1995; 90: 1250-7.
6. Knodell RG, Ishak KG, Black WC et al Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
7. Scheuer PJ. Classification of chronic hepatitis: a need for reassessment. J. Hepatol. 1991; 13: 372-4.
8. Hytiroglou P, Thung SN, Gerber MA. Histological classification and quantitation of the severity of chronic hepatitis: keep it simple! Semin. Liver Dis. 1995; 15: 414-21.
9. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
10. Garson JA,Tedder RS, Briggs M et al. Detection of hepatitis C viral sequences in blood donations by 'nested' polymerase chain reaction and prediction of infectivity. Lancet 1990; 335: 1419-22.
11. Okamoto H, Okada S, Sugiyama Y et al. Detection of hepatitis C viral RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J. Exp. Med. 1990; 60: 215-22.
12. Lau JYN, Davis G, Kniffen J et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-4.
13. Hwang S-J, Lee S-D, Chan C-Y, Lu R-H, Lo K-J. A randomized controlled trial of recombinant Interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J. Hepatol. 1994; 21: 831-6.
14. Naito M, Hayashi N, Hagiwara H et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994; 19: 871-5.
15. Kao J-H, Lai M-Y, Chen P-J, Hwang L-H, ChenW, Chen D-S. Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis. Am. J. Gastroenterol. 1996; 91: 506-10.
16. Cheung RC, Chan RT, Lok ASF. Longitudinal study of hepatitis C viremia in chronic hepatitis C. J. Med. Virol. 1993; 41: 338-42.
17. Yuki N, Hayashi N, Kamada T. HCV viraemia and liver injury in symptom-free blood donors. Lancet 1993; 342: 444-5.
18. Kumar U, Thomas HC, Monjardino J. Serum HCV RNA levels in chronic HCV hepatitis measured by quantitative PCR assay: correlation with serum AST. J. Virol. Methods 1994; 47: 95-102.
19. Gretch D, Corey L, Wilson J et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J. Infect. Dis. 1994; 169: 1219-25.
20. Cha TA, Beall E, Irvine B et al. At least five related, but distinct, hepatitis C viral genotypes exist. Proc. Natl Acad. Sci. USA 1992; 89: 7144-8.
21. Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-4.
22. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronichepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatolgy 1996; 23: 695-9.
23. Tsubota A, Chayama K, Ikeda K et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088-94.
24. Silini E, Bottelli R, Asti M et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology 1996; 111: 199-205.
25. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 1992; 73: 673-9.
26. Simmonds P, McOmish F, Yap PL et al. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J. Gen. Virol. 1993; 74: 661-8.
27. Sheen IS, Liaw YF, Lin DY, Chu CM. Acute exacerbation in chronic hepatitis C: a clinicopathological and prognostic study. J. Hepatol. 1996; 24: 525-31.
28. Persico M, Romano M. Alanine aminotransferase measurements and histological disease in hepatitis C. Lancet 1993; 342: 1369-70.
29. Hiramatsu N, Hayashi N, Haruna Y et al. Immunohistological detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 1992; 16: 306-11.
30. Cahen DL, van Leeuwen DJ, ten Kate FJW, Blok APR, Oosting J, Chamuleau RAFM. Do serum ALAT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis? Liver 1996; 16: 105-9.
31. Davis GL, Balart LA, Schiff ER et al. Treatment of chronic hepatitis C with recombinant Interferon alfa. N. Engl. J. Med. 1989; 321: 1501-5.
32. Di Bisceglie AM, Martin P, Kassianides C et al. Recombinant Interferon alfa therapy for chronic hepatitis C. N. Engl. J. Med. 1989; 321: 1506-10.
33. Kato N,Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20.
34. Mita E, Hayashi N, Kanazawa Y et al. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J. Hepatol. 1994; 21: 468-73.